The process of identifying a suitable drug target for any given disease (inherited or otherwise) can be an extremely long process; translational research, drug discovery and clinical trials all mean that identifying and issuing a treatment can take decades and a considerable amount of money.
The ‘Partnership for Cures’ program funds drug repurposing projects enabling so-called ‘orphan diseases’ to be treated with existing therapies, foregoing the lengthy clinical trial process and massive costs, since such products have already been rigorously tested and approved.
There are currently several projects in the pipeline evaluating possible‘re-purposed’ therapies for BHD Syndrome, making this an extremely exciting time.
www.BHDSyndrome.org – the primary reference site for anybody interested in BHD Syndrome
ScienceBlog.com has no paywalls, no sponsored content, and no agenda beyond getting the science right. Every story here is written to inform, not to impress an advertiser or push a point of view.
Good science journalism takes time — reading the papers, checking the claims, finding researchers who can put findings in context. We do that work because we think it matters.
If you find this site useful, consider supporting it with a donation. Even a few dollars a month helps keep the coverage independent and free for everyone.